These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 19293183)

  • 41. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
    Kim ES; Kim MS; Moon A
    Int J Oncol; 2004 Nov; 25(5):1375-82. PubMed ID: 15492828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
    Leu FP; Nandi M; Niu C
    Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
    Mercado-Pimentel ME; Runyan RB
    Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
    Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
    Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis.
    Shimizu M; Kondo S; Urushihara M; Takamatsu M; Kanemoto K; Nagata M; Kagami S
    Nephrol Dial Transplant; 2006 Sep; 21(9):2380-90. PubMed ID: 16728424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33.
    Kim AH; Lebman DA; Dietz CM; Snyder SR; Eley KW; Chung TD
    Int J Oncol; 2003 Dec; 23(6):1593-9. PubMed ID: 14612931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells.
    Miyazaki YJ; Hamada J; Tada M; Furuuchi K; Takahashi Y; Kondo S; Katoh H; Moriuchi T
    Oncogene; 2002 Jan; 21(5):798-808. PubMed ID: 11850808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mammary epithelial cells treated concurrently with TGF-alpha and TGF-beta exhibit enhanced proliferation and death.
    Casey TM; Mulvey TM; Patnode TA; Dean A; Zakrzewska E; Plaut K
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1027-40. PubMed ID: 17720949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition.
    Maeda M; Johnson KR; Wheelock MJ
    J Cell Sci; 2005 Mar; 118(Pt 5):873-87. PubMed ID: 15713751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
    Gemma A; Uematsu K; Hagiwara K; Takenoshita S; Kudoh S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor-β enhances epithelial to mesenchymal transition in lung and pancreatic tumor models.
    Argast GM; Mercado P; Mulford IJ; O'Connor M; Keane DM; Shaaban S; Epstein DM; Pachter JA; Kan JL
    Cells Tissues Organs; 2011; 193(1-2):114-32. PubMed ID: 21041998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
    Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
    Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
    Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells.
    Patel P; West-Mays J; Kolb M; Rodrigues JC; Hoff CM; Margetts PJ
    Matrix Biol; 2010 Mar; 29(2):97-106. PubMed ID: 19896531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
    Cicchini C; Laudadio I; Citarella F; Corazzari M; Steindler C; Conigliaro A; Fantoni A; Amicone L; Tripodi M
    Exp Cell Res; 2008 Jan; 314(1):143-52. PubMed ID: 17949712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells.
    Sokol JP; Schiemann WP
    Mol Cancer Res; 2004 Mar; 2(3):183-95. PubMed ID: 15037657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
    Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
    Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.